Clinical utility of C-reactive protein-to-albumin ratio in the management of patients with inflammatory bowel disease.

Anke L NguyenClaudia BrickDavid LiuDavid J GibsonPeter R GibsonMiles P Sparrow

Published in: JGH open : an open access journal of gastroenterology and hepatology (2024)

CAR was only a modest discriminator of subtherapeutic infliximab levels and offers little more than CRP in detecting active disease. CAR has potential to detect severe Mayo 3 disease and could be calculated in patients admitted with suspected acute severe ulcerative colitis.

Keyphrases

ulcerative colitis
patients with inflammatory bowel disease
drug induced
early onset
liver failure
pulmonary embolism
respiratory failure
intensive care unit
aortic dissection
climate change